4,321
Views
18
CrossRef citations to date
0
Altmetric
Poison Centre Research

Physostigmine is superior to non-antidote therapy in the management of antimuscarinic delirium: a prospective study from a regional poison center

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 50-55 | Received 26 Mar 2018, Accepted 29 May 2018, Published online: 29 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Matthew S. Correia & Robert G. Hendrickson. (2023) Improvement in delirium and visuospatial function after rivastigmine in antimuscarinic toxicity: a case report. Toxicology Communications 7:1.
Read now
Kevin Baumgartner, Michelle Doering and & Michael E. Mullins. (2022) Dexmedetomidine in the treatment of toxicologic conditions: a systematic review and review of the toxicology investigators consortium database. Clinical Toxicology 60:12, pages 1356-1375.
Read now

Articles from other publishers (16)

Spencer C. Greene. (2023) Rivastigmine Use in the Treatment of Antimuscarinic Delirium. Journal of Medical Toxicology 19:3, pages 284-287.
Crossref
James D. Whitledge, Pelayia Soto, Kieran M. Glowacki, Erin R. Fox & Maryann Mazer-Amirshahi. (2023) Shortages of agents used to treat antimuscarinic delirium. The American Journal of Emergency Medicine 67, pages 163-167.
Crossref
Jason Seebaluck, Michael A. Downes, Jared Brown, Keith Harris, Katherine Z. Isoardi & Betty S. Chan. (2022) Case series profile of olanzapine post‐injection delirium/sedation syndrome. British Journal of Clinical Pharmacology 89:2, pages 903-907.
Crossref
Mohamed Farah Yusuf Mohamud & Mohamud Mire Waberi. (2022) Pheniramine induced supraventricular tachycardia resistant to adenosine: A case report and review. Annals of Medicine and Surgery 78, pages 103621.
Crossref
Sophie Gosselin & Robert S. Hoffman. (2022) The Management of Agitated Toxidromes. Emergency Medicine Clinics of North America 40:2, pages 223-235.
Crossref
Michael E. Mullins. (2021) Physostigmine should be used more readily for antimuscarinic toxicity: CON. British Journal of Clinical Pharmacology 88:1, pages 61-63.
Crossref
Nathan Kunzler & Timothy B. Erickson. 2022. History of Modern Clinical Toxicology. History of Modern Clinical Toxicology 271 278 .
Mohamed Serhan Hamam & Andrew Bissonette. (2021) Evaluation and Management of Toxicological Causes of Delirium. Current Emergency and Hospital Medicine Reports 9:3, pages 55-63.
Crossref
Mitchell Zekhtser, Erin Carroll, Molly Boyd & Shashikanth Ambati. (2021) The Role of Dexmedetomidine in Pediatric Patients Presenting with an Anticholinergic Toxidrome. Case Reports in Critical Care 2021, pages 1-5.
Crossref
Wilmarie Cidre Serrano & Jose Maldonado. (2021) The Use of Physostigmine in the Diagnosis and Treatment of Anticholinergic Toxicity After Olanzapine Overdose: Literature Review and Case Report. Journal of the Academy of Consultation-Liaison Psychiatry 62:3, pages 285-297.
Crossref
I Plaetinck, J Heerman, S Van De Velde, S Allaert & A.F. Kalmar. (2022) Anticholinergic symptoms in a patient with a bupropion overdose successfully managed with physostigmine: a case report. Acta Anaesthesiologica Belgica 72:1, pages 49-52.
Crossref
Laura M. Tormoehlen. 2021. Emergency Neurology. Emergency Neurology 373 401 .
A.F. Kalmar, I Plaetinck, J Heerman, S Van De Velde & S Allaert. (2022) Anticholinergic symptoms in a patient with a bupropion overdose successfully managed with physostigmine: a case report. Acta Anaesthesiologica Belgica 71:3, pages 137-140.
Crossref
Nicole M Acquisto, Giles W Slocum, Matthew H Bilhimer, Nadia I Awad, Stephanie Baker Justice, Gregory F Kelly, Therese Makhoul, Asad E Patanwala, Gary D Peksa, Blake Porter, Donna M Shuler Truoccolo, Cierra N Treu, Kyle A Weant & Michael C Thomas. (2020) Key articles and guidelines for the emergency medicine clinical pharmacist: 2011-2018 update. American Journal of Health-System Pharmacy 77:16, pages 1284-1335.
Crossref
Raghad Saadi & Kristin Bohnenberger. (2020) Physostigmine for Antimuscarinic Toxicity. Journal of Emergency Nursing 46:1, pages 126-128.
Crossref
Sean P. Boley & Samuel J. Stellpflug. (2019) A Comparison of Resource Utilization in the Management of Anticholinergic Delirium Between Physostigmine and Nonantidote Therapy. Annals of Pharmacotherapy 53:10, pages 1026-1032.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.